(VIANEWS) - Texas Pacific Land (TPL), Perion Network Ltd (PERI), Eli Lilly and Company (LLY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Texas Pacific Land (TPL)
30.3% sales growth and 47.49% return on equity
Texas Pacific Land Corporation is engaged in land and resource management and water services operations. Land and Resource Management is responsible for approximately 880,000 acres. The segment holds a 1/128th perpetual nonparticipating oil and gas royalty interest, (NPRI), under about 85,000 acres; a 1/4th NPRI under roughly 371,000 acres; and around 4,000 net royalty acres in the western portion of Texas. This segment also engages in commercial and easements activities such as subsurface wellbore and power line easements, utility and power line easements and oil and gas. This segment also leases land to process, store, compress, and make roads. It is also involved in the sale of material, like caliche. The Water Services and Operations segment offers full-service water services, such as water sourcing and produced-water gathering/treatment. It also provides infrastructure development and disposal solutions. Well testing and analytics are provided to Permian Basin operators. It also receives royalties from water that it has sourced. Texas Pacific Land Corporation was established in 1888. It is located in Dallas, Texas.
Texas Pacific Land's sales growth this year is anticipated to be 37.1% and 1.8% for next year.
Year-on-year quarterly revenue growth grew by 97.6%, now sitting on 450.96M for the twelve trailing months.
Volume
Today's last reported volume for Texas Pacific Land is 18013 which is 37.67% below its average volume of 28903.
Texas Pacific Land's sales growth for the next quarter is 30.3%. The company's growth estimates for the ongoing quarter and the next is 80.4% and 26.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.49%.
Volatility
Texas Pacific Land's last day, last week, and last month's current intraday variation average was 4.06%, 3.94%, and 2.28%, respectively.
Texas Pacific Land's highest amplitude of average volatility was 3.97% (day), 3.77% (last week), and 3.85% (last month), respectively.
Texas Pacific Land's Stock Yearly Top and Bottom Value
Texas Pacific Land's stock is valued at $1,710.45 at 11:22 EST, below its 52-week high of $1,756.00 and way higher than its 52-week low of $946.29.
Texas Pacific Land's Moving Average
Texas Pacific Land's value is way higher than its 50-day moving average of $1,473.79 and way higher than its 200-day moving average of $1,295.95.2. Perion Network Ltd (PERI)
30.1% sales growth and 13.81% return on equity
Perion Network Ltd. offers digital advertising solutions for brands, publishers, and agencies in North America, Europe and worldwide. The company offers Wildfire, which is a content-monetization platform, as well as search monetization options, such search mediation and website monetization. It also provides cross-channel digital advertising software, as a platform. It also provides a supply management platform and demand management platform. The analytics platform gives information on campaign performance and offers insight into campaign results. There is also a creative platform to make advertisements. An AI platform uses machine learning to provide intelligence for the different phases of campaigns. It also offers an integrated online video player with integrated ad server that allows you to upload, manage and stream video content. The content monetization platform integrates ads into the page layouts. The company also offers an analytics and performance optimization tool, reports, search-demand management systems, monetization products, and products that onboard and integrate demand vendors. It also offers Intelligent HUB (iHUB), which is a platform that pulls in signals from various channels, optimizes traffic at scale and yields engagement metrics, KPIs, and KPIs. Also, the company provides strategic optimization of pertinent traits (SORT), which is a provisional technology for eliminating the use of cookies. IncrediMail Ltd. was the company's previous name. In November 2011, Perion Network Ltd. became Perion Network Ltd. Perion Network Ltd. was established in 1999. It is located in Holon in Israel.
Perion Network Ltd's sales growth this year is expected to be 31.2% and 16.4% for next year.
Year-on-year quarterly revenue growth grew by 39.5%, now sitting on 514M for the twelve trailing months.
Volume
Today's last reported volume for Perion Network Ltd is 247994 which is 28.51% below its average volume of 346898.
Perion Network Ltd's sales growth for the next quarter is 30.1%. The company's growth estimates for the present quarter and the next is 68.4% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.81%.
Volatility
Perion Network Ltd's last day, last week, and last month's current intraday variation average was 2.25%, 2.88%, and 3.34%, respectively.
Perion Network Ltd's highest amplitude of average volatility was 2.86% (day), 4.72% (last week), and 4.65% (last month), respectively.
Perion Network Ltd's Stock Yearly Top and Bottom Value
Perion Network Ltd's stock is valued at $21.73 at 11:23 EST, way below its 52-week high of $33.09 and way higher than its 52-week low of $16.41.
Perion Network Ltd's Moving Average
Perion Network Ltd's worth is way higher than its 50-day moving average of $19.24 and below its 200-day moving average of $21.73.3. Eli Lilly and Company (LLY)
15.1% sales growth and 74.02% return on equity
Eli Lilly and Company develops and markets pharmaceuticals for human use worldwide. Basaglar is available, as well as Humalog Mix 75/25 and Humalog U100. Humalog U200 and Humalog Mix 50/50. It also offers insulin lispro and insulin lispro antitamine. Insulin lispro 75/25 and insulin lispro mix 75/25. Humulin U500, Humulin U-50, Humulin U-30, Humulin U, Humulin U, Humulin U, Humulin U, Trajenta and Trulicity, Trajenta and Trulicity to treat type 2. Alimta is available for the treatment of non-small-cell lung cancer. Olumiant is available for rheumatoid arthritis; Taltz can be used for plaque psoriasis and psoriatic arthritis. Cymbalta is available for depression, diabetes peripheral neuropathic, anxiety disorder and fibromyalgia; Emgality can prevent migraines and treat episodic cluster headaches; Zyprexa is for schizophrenia and bipolar I disorder; as well as bipolar maintenance. Bamlanivimab is available for COVID-19, as well as etesevimab and Bebtelovimab. Cialis can be used for benign prostatic hyperplasia and erectile dysfunction. Forteo treats osteoporosis. It has collaborated with Incyte Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Junshi Biosciences, Regor Therapeutics Group, Lycia Therapeutics, Inc., Kumquat Biosciences Inc., Entos Pharmaceuticals Inc., and Foghorn Therapeutics Inc.
Eli Lilly and Company's sales growth this year is expected to be 10.8% and 5.2% for next year.
Year-on-year quarterly revenue growth grew by 14.8%, now sitting on 29.32B for the twelve trailing months.
Volume
Today's last reported volume for Eli Lilly and Company is 2434950 which is 14.6% below its average volume of 2851340.
Eli Lilly and Company's sales growth is a negative 0% for the current quarter and 15.1% for the next. The company's growth estimates for the current quarter and the next is 5% and 11.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 74.02%.
Volatility
Eli Lilly and Company's last day, last week, and last month's current intraday variation average was 1.91%, 1.42%, and 1.16%, respectively.
Eli Lilly and Company's highest amplitude of average volatility was 2.60% (day), 2.27% (last week), and 2.19% (last month), respectively.
Eli Lilly and Company's Stock Yearly Top and Bottom Value
Eli Lilly and Company's stock is valued at $321.90 at 11:23 EST, under its 52-week high of $335.33 and way higher than its 52-week low of $220.20.
Eli Lilly and Company's Moving Average
Eli Lilly and Company's value is above its 50-day moving average of $315.22 and way above its 200-day moving average of $280.84.4. Independent Bank Group (IBTX)
11.8% sales growth and 8.54% return on equity
Independent Bank Group, Inc. is the bank holding firm for Independent Bank. It provides various banking services and products to individuals, businesses, and professionals in the United States. You can deposit in checking, savings, demand deposits and money market accounts. It also offers commercial real estate loans. It also offers mobile and online banking, direct deposit, eStatement and bank-by-mail services and debit cards. The company had 93 branches as of December 31, 2020. Independent Bank Group, Inc. was established in 2002. It is located in McKinney, Texas.
Independent Bank Group's sales growth this year is expected to be 6.1% and 9.7% for next year.
Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 590.63M for the twelve trailing months.
Volume
Today's last reported volume for Independent Bank Group is 23550 which is 88.3% below its average volume of 201322.
Independent Bank Group's sales growth for the next quarter is 11.8%. The company's growth estimates for the present quarter and the next is 11.6% and 12.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.54%.
Volatility
Independent Bank Group's last day, last week, and last month's current intraday variation average was 0.34%, 0.91%, and 1.09%, respectively.
Independent Bank Group's highest amplitude of average volatility was 1.96% (day), 1.86% (last week), and 2.20% (last month), respectively.
Independent Bank Group's Stock Yearly Top and Bottom Value
Independent Bank Group's stock is valued at $74.52 at 11:23 EST, below its 52-week high of $79.66 and way above its 52-week low of $62.82.
Independent Bank Group's Moving Average
Independent Bank Group's worth is above its 50-day moving average of $69.54 and above its 200-day moving average of $72.30.5. Axcelis Technologies (ACLS)
10.7% sales growth and 27.58% return on equity
Axcelis Technology, Inc. manufactures and provides services for ion implantation and processing equipment that is used to fabricate semiconductor chips in America, Europe and Asia. For various applications, the company provides high-energy, high-current, and medium-current implanters. The company also offers aftermarket services and products, such as spare parts, used tools, upgrades and maintenance, customer training, and equipment replacements. Through its direct sales force, it sells equipment and other services to manufacturers of semiconductor chips. Beverly, Massachusetts is the headquarters of the company.
Axcelis Technologies's sales growth this year is anticipated to be 32.4% and 6.2% for next year.
Year-on-year quarterly revenue growth grew by 50.2%, now sitting on 807.15M for the twelve trailing months.
Volume
Today's last reported volume for Axcelis Technologies is 741833 which is 96.36% above its average volume of 377775.
Axcelis Technologies's sales growth for the next quarter is 10.7%. The company's growth estimates for the ongoing quarter and the next is 37.8% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.58%.
Volatility
Axcelis Technologies's last day, last week, and last month's current intraday variation average was 8.80%, 5.28%, and 3.64%, respectively.
Axcelis Technologies's highest amplitude of average volatility was 7.89% (day), 6.54% (last week), and 5.22% (last month), respectively.
Axcelis Technologies's Stock Yearly Top and Bottom Value
Axcelis Technologies's stock is valued at $76.87 at 11:24 EST, below its 52-week high of $83.74 and way higher than its 52-week low of $41.31.